Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
USP1 is a deubiquitinating enzyme (DUB) belonging to the UBP family. It plays a crucial role in DNA damage response and repair by regulating the ubiquitylation status of key proteins like FANCD2, FANCI, and PCNA. USP1 is involved in the Fanconi anemia pathway and autophagy regulation. It is a therapeutic target in cancer, particularly in BRCA-mutant tumors, where its inhibition shows synthetic lethality with PARP inhibitors.
Inhibition of USP1 activity leads to accumulation of ubiquitinated substrates and disruption of DNA repair pathways.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin specific peptidase 1 (USP1).